Tuesday, August 23, 2016 10:51:19 AM
FROM THE FDA
.......In addition, your Marketwired September 26, 2013, press release reported
that Sucanon (the trade name for your dietary supplement containing the new dietary
ingredient) is a treatment for Type II diabetes.2 A product intended for use as a drug within
the meaning of21 U.S.C. 321(g)(l)(B) is subject to regulation under the drug provisions of
the Act. You should contact. FDA's Center for Drug Evaluation and Research (CDER), Office
ofCompliance, 10903 New Hampshire Avenue, W05 1-51 85, Silver Spring, MD 20993-0002.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM